Display options
Share it on

Eur J Transl Myol. 2021 Jan 14;30(4):9302. doi: 10.4081/ejtm.2020.9302. eCollection 2020 Dec 31.

Coronavirus syndrome: COVID-19 psychotrauma.

European journal of translational myology

Nadezhda V Soloveva, Ekaterina V Makarova, Irina V Kichuk

Affiliations

  1. Joint-stock company "Scientific Center of Personalized Medicine", Moscow, Russia.
  2. Somatic rehabilitation, reproductive health and active aging department of Federal Atate Budgetary Institution "National Medical Research Center of Rehabilitation and Balneology" of the Ministry of Health of Russian Federation, Moscow, Russia.
  3. Department of Neurology, Neurosurgery and Medical Genetics of the Medical Faculty of the N.I. Pirogov Russian National Research Medical University, Moscow, Russia.

PMID: 33520144 PMCID: PMC7844407 DOI: 10.4081/ejtm.2020.9302

Abstract

The authors propose term "coronavirus syndrome" for the mental disorder that is a psychical response to the global problem of COVID-19 pandemic. This syndrome will affect up to 10% of the population and we could already observe acute stress reactions to the spread of the infection and changes in people's ordinary lifestyle. However, the most severe response will be seen later, in this case the catastrophe is similar to the clinical picture of post-traumatic stress disorder. The problem is that coronavirus syndrome will affect the working capacity of population at the period, when economical recovery is essential. The risk groups are health caregivers who worked in COVID departments; patients recovered from a severe form of the disease; people who have lost their loved ones; and those who have suffered significant financial losses or lost their jobs. Adequate prophylaxis of coronavirus syndrome especially in high-risk groups are important for maintaining global mental health and economy.

Keywords: COVID-19; mental health; perspectives; post-traumatic stress disorder; prophylaxis; social stress disorder

Conflict of interest statement

We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

References

  1. Lancet. 2007 Jan 13;369(9556):139-44 - PubMed
  2. Arch Gen Psychiatry. 1995 Dec;52(12):1048-60 - PubMed
  3. Behav Res Ther. 2015 Dec;75:40-7 - PubMed
  4. Genes Brain Behav. 2017 Jan;16(1):15-43 - PubMed
  5. Brain Sci. 2020 Mar 13;10(3): - PubMed
  6. Br J Psychiatry. 2005 Jun;186:467-72; discussion 473-5 - PubMed
  7. Front Psychiatry. 2017 May 19;8:85 - PubMed
  8. J Psychiatr Res. 2018 Jul;102:81-86 - PubMed
  9. Clin Psychol Rev. 2013 Aug;33(6):728-44 - PubMed
  10. J Affect Disord. 2011 Jun;131(1-3):243-50 - PubMed
  11. Chest. 2013 Sep;144(3):766-777 - PubMed
  12. J Affect Disord. 2012 Apr;138(1-2):96-103 - PubMed
  13. J Affect Disord. 2005 Sep;88(1):79-86 - PubMed
  14. J Clin Neurosci. 2017 Jan;35:109-116 - PubMed
  15. Eur J Psychotraumatol. 2017 Oct 17;8(1):1386988 - PubMed
  16. Am J Addict. 2015 Jan;24(1):39-46 - PubMed
  17. Am J Psychiatry. 1996 Mar;153(3):369-75 - PubMed
  18. Cochrane Database Syst Rev. 2013 Dec 13;(12):CD003388 - PubMed
  19. Am Psychol. 2011 Sep;66(6):429-46 - PubMed
  20. J Exp Biol. 2013 Dec 1;216(Pt 23):4435-42 - PubMed
  21. Psychiatr Clin North Am. 2002 Jun;25(2):341-68, vii - PubMed
  22. Am J Psychiatry. 2000 Jul;157(7):1120-6 - PubMed
  23. Am J Psychiatry. 2004 Feb;161(2):195-216 - PubMed
  24. Clin EEG Neurosci. 2010 Oct;41(4):196-202 - PubMed
  25. J Consult Clin Psychol. 2000 Oct;68(5):748-66 - PubMed
  26. Emotion. 2008 Aug;8(4):560-72 - PubMed
  27. Front Public Health. 2018 Dec 21;6:373 - PubMed
  28. Psychopharmacology (Berl). 2004 Oct;175(4):494-502 - PubMed
  29. World Psychiatry. 2002 Oct;1(3):158-9 - PubMed

Publication Types